August 24, 2020 Update: The U.S. Food and Drug Administration issued an Emergency Use Authorization on August 23, 2020 for emergency use of convalescent plasma for the treatment of hospitalized patients with severe COVID-19. A clinical trial testing the investigational use of convalescent plasma for COVID-19 is closed to participant enrollment at Sutter.
Heart transplant patient Mick Doughty, center, presented Sutter Medical Center, Sacramento with the Comprehensive Cardiac Center certification in 2023. The hospital recently was recertified by The Joint Commission and the American Heart Association after a rigorous...
Timing is everything. That can be especially true in healthcare. Now think of how AI can accelerate clinical decisions and treatment. That is some of the promising potential with a new real-time AI operating system by Aidoc launching inside Sutter Health, a leading...
Celebrating Independence Day with barbecues, picnics and fireworks is a cherished American tradition — but it also comes with risks. Home fireworks can lead to serious injuries, spark fires and even trigger those living with post-traumatic stress disorder. To help...
Editor’s Note: Welcome to the first installment of “A Summer of Learning” at Sutter Health. This series will examine how Sutter, through its academic partnerships, is working to expand access to healthcare by building a stronger, more robust pathway of...